Dancann Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dancann Pharma
Access all reports
The company, through its subsidiary Kron Medical ApS, develops a portfolio of novel cannabinoid therapies on the basis of patented technology platforms in the areas of pain, cancer, and brain diseases/disorders. It is also developing medicines for the treatment of infantile spasms or seizures; and a class of drugs for the treatment of various conditions caused by redox signalling imbalance. The company was founded in 2015 and is based in Odense, Denmark
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
DANCAN
Country
🇩🇰 Denmark